Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
15.0%
% of XPH's 40 holdings also in MEDX
20.0%
% of MEDX's 30 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 5.1% | 5.2% | 5.1% |
|
ELI LILLY & CO | 4.8% | 15.1% | 4.8% |
|
JOHNSON & JOHNSON | 4.5% | 4.5% | 4.5% |
|
PFIZER INC | 4.9% | 4.3% | 4.3% |
|
BRISTOL-MYERS SQUIBB CO | 4.0% | 4.7% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to MEDX
|
ORGANON & CO. | 5.3% |
|
ELANCO ANIMAL HEALTH, INC. | 5.0% |
 |
PERRIGO CO | 4.8% |
|
CATALENT INC | 4.7% |
|
AXSOME THERAPEUTICS, INC. | 4.7% |
|
INTRA-CELLULAR THERAPIES INC | 4.6% |
|
JAZZ PHARMACEUTICALS PLC | 4.5% |
|
ZOETIS INC | 4.5% |
|
ROYALTY PHARMA PLC CLASS A | 4.4% |
|
VIATRIS, INC. | 4.1% |
XPH Underweight Relative to MEDX
|
ELI LILLY & CO | -10.3% |
|
ABBVIE INC | -7.3% |
|
AMGEN INC | -6.1% |
 |
NOVARTIS AG-ADR | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.7% |
|
REGENERON PHARMACEUTICALS | -4.1% |
|
BIOGEN IDEC INC | -4.1% |
|
ALKERMES PLC | -3.3% |
|
CRISPR THERAPEUTICS AG | -3.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.0% |